EUVIMEDEUVIMED entdecken
Crossref

Is HLA‐DQ typing useful in screening for celiac disease among Arabs with type 1 diabetes? A case–control study

Abdulrahman Al-Hussaini, Abdulhameed Alsaheel, Mussa AlMalki, Riccardo Troncone, Hanan Alharthi iD, Nezar Eltayeb-Elsheikh, Ghadeer Alshammari, Shawana Zaheer Allah, Ghadeer Aldossari, Norah AlRajhi, Fatimah Abdulkareem, Ahmed Alzahrani und 3 weitere

Journal of Pediatric Gastroenterology and Nutrition · 2024

DOI: 10.1002/jpn3.12385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Abdulrahman Al-Hussaini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Children's Specialized Hospital, King Fahad Medical City, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Celiac Disease, Diabetes Mellitus, Type 1, HLA-DQ Antigens, Arabs. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Research Center at King Fahad Medical City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The data on the usefulness of DQ ‐typing in screening for celiac disease (CD) among type 1 diabetic (T1D) patients came from the West. We conducted this study among T1D patients to: (1) determine the frequency of DQ‐ genotypes, (2) assess the risk associated with human leukocyte antigen ( HLA ) ‐DQ genotypes, and (3) identify the cost‐effective screening strategy.

Methods

HLA‐ DQ genotyping was performed on 67 T1D patients with CD (cases) (mean age 15 years) and 224 T1D patients without CD (controls) (mean age 18.29 years) (2021–2023). The entry criterion for the control group was duration of T1D ≥5 years and negative annual celiac serology assay.

Results

On comparison of the cases versus controls, T1D patients carrying homozygous DQ 2.5 genotype (30% vs. 13.8%) or DR3‐DQ2.5 haplotype (81.3% vs. 65.7%) showed significantly “higher risk” (odds ratio [OR] = 2.64, p = 0.002; OR = 2.3, p = 0.008, respectively) to develop CD. Only 4% do not harbor any of the CD‐at risk genotypes ( DQ2.5 , DQ8 , or DQ2.2 ) and none developed CD. Heterozygous DQ8 was associated with a significantly lower risk of developing CD with OR of 0.123 (1.5% in cases vs. 10.3% in controls, p = 0.022).

Conclusion

Only 4% of Saudi patients with T1D carry DQ ‐genotypes at no risk to develop CD, which supports the European guidelines that recommend celiac serology test as the most cost‐effective screening method. We identified the risk gradient associated with DQ ‐genotypes to develop CD in our population which could help in counseling patients for the risk to develop CD and planning follow‐up serology tests.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseDiabetes Mellitus, Type 1HLA-DQ AntigensArabsHumansAdolescentCase-Control StudiesFemaleMaleChildYoung AdultGenotypeGenetic Predisposition to DiseaseAdultMass Screening

Stichwörter der Autor:innen

DQ‐genotypeSaudi Arabiacost‐effectiveness

Substanzen

HLA-DQ Antigens

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Children's Specialized Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
  • College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Prince Abdullah Bin Khaled Celiac Disease Research Chair, Department of Pediatrics, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Pediatric Endocrinology Department, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Obesity, Endocrine, and Metabolism Center, Department of Endocrinology, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Translational Sciences & European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, Naples, Italy.

ORCID-Profile: Hanan Alharthi, Muhammed Salman Bashir

Förderung

  • Research Center at King Fahad Medical City

Zitieren

APA

Al-Hussaini, A., Alsaheel, A., AlMalki, M., Troncone, R., Alharthi, H., Eltayeb-Elsheikh, N., Alshammari, G., Allah, S. Z., Aldossari, G., AlRajhi, N., Abdulkareem, F., Alzahrani, A., AlNemer, O., AlMazrou, L., & Bashir, M. S. (2024). Is HLA‐DQ typing useful in screening for celiac disease among Arabs with type 1 diabetes? A case–control study. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12385

Vancouver

Al-Hussaini A, Alsaheel A, AlMalki M, Troncone R, Alharthi H, Eltayeb-Elsheikh N, et al. Is HLA‐DQ typing useful in screening for celiac disease among Arabs with type 1 diabetes? A case–control study. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12385

BibTeX
@article{AlHussaini2024,
  author = {Al-Hussaini, Abdulrahman and Alsaheel, Abdulhameed and AlMalki, Mussa and Troncone, Riccardo and Alharthi, Hanan and Eltayeb-Elsheikh, Nezar and Alshammari, Ghadeer and Allah, Shawana Zaheer and Aldossari, Ghadeer and AlRajhi, Norah and Abdulkareem, Fatimah and Alzahrani, Ahmed and AlNemer, Ola and AlMazrou, Lulwa and Bashir, Muhammed Salman},
  title = {Is HLA‐DQ typing useful in screening for celiac disease among Arabs with type 1 diabetes? A case–control study},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  doi = {10.1002/jpn3.12385}
}
Kostenlos starten →